These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


250 related items for PubMed ID: 1624030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Limited role for intratubal methotrexate treatment of ectopic pregnancy.
    Shalev E, Peleg D, Bustan M, Romano S, Tsabari A.
    Fertil Steril; 1995 Jan; 63(1):20-4. PubMed ID: 7805915
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial.
    Casikar I, Lu C, Reid S, Bignardi T, Mongelli M, Morris A, Wild R, Condous G.
    Rev Recent Clin Trials; 2012 Aug; 7(3):238-43. PubMed ID: 22540910
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
    Nowak-Markwitz E, Michalak M, Olejnik M, Spaczynski M.
    Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
    [Abstract] [Full Text] [Related]

  • 10. Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment.
    Hutchinson AP, Pereira N, Chung ER, Shah NJ, Zeku M, Chung PH, Rosenwaks Z.
    Gynecol Endocrinol; 2019 Jan; 35(1):49-52. PubMed ID: 30322280
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
    Helmy S, Bader Y, Pablik E, Tiringer D, Pils S, Laml T, Kölbl H, Koch M.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
    van Mello NM, Mol F, Verhoeve HR, van Wely M, Adriaanse AH, Boss EA, Dijkman AB, Bayram N, Emanuel MH, Friederich J, van der Leeuw-Harmsen L, Lips JP, Van Kessel MA, Ankum WM, van der Veen F, Mol BW, Hajenius PJ.
    Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of methotrexate treatment in extrauterine pregnancies defined by stable or increasing human chorionic gonadotropin concentrations.
    Gamzu R, Almog B, Levin Y, Avni A, Jaffa A, Lessing JB, Baram A.
    Fertil Steril; 2002 Apr; 77(4):761-5. PubMed ID: 11937130
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.